Literature DB >> 10519368

Polymorphism in the tumor necrosis factor B gene is associated with Palmoplantar pustulosis.

K Hashigucci1, M Yokoyama, H Niizeki, Y Yamasaki, K Akiya, T Tojo, T Urushibara, Y Yamazaki, H Shimizu, T Nishikawa.   

Abstract

We investigated the allele and genotype distribution of a polymorphism of the tumor necrosis factor (TNF) B gene and the frequency of HLA-DR9 in 49 patients with Palmoplantar pustulosis (PPP) and 51 healthy controls. We found that the frequency of TNFB2 in the PPP patients was significantly higher than that in the controls. Furthermore, the DR9-TNFB2 haplotype was significantly more frequent in the PPP patients (P=0.0045). These results suggest that TNFB2 may confer susceptibility to PPP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519368     DOI: 10.1034/j.1399-0039.1999.540312.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris.

Authors:  T Yoshizaki; N Bandoh; S Ueda; H Nozawa; T Goto; K Kishibe; M Takahara; Y Harabuchi
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

2.  Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Authors:  D Baeten; E Kruithof; F Van den Bosch; N Van den Bossche; A Herssens; H Mielants; F De Keyser; E M Veys
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

3.  Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris.

Authors:  Robert Bissonnette; Mayte Suárez-Fariñas; Xuan Li; Kathleen M Bonifacio; Carrie Brodmerkel; Judilyn Fuentes-Duculan; James G Krueger
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.